“…Although rifampin has been implicated as a cause of thrombocytopenia, this adverse effect has been described primarily in the setting of complex TB regimens. [3][4][5][6][7] While early reports described hematologic toxicities with ≥600 mg/ day, it should be noted that toxicities have also occurred with lower intermittent dosing regimens. [3][4][5][6][7] Therefore, the 300-to 450-mg twice-daily rifampin regimens recommended for PJIs may place patients at increased risk of developing hematologic toxicities.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5][6][7] While early reports described hematologic toxicities with ≥600 mg/ day, it should be noted that toxicities have also occurred with lower intermittent dosing regimens. [3][4][5][6][7] Therefore, the 300-to 450-mg twice-daily rifampin regimens recommended for PJIs may place patients at increased risk of developing hematologic toxicities. 1,2 Utilization of the Naranjo adverse drug reaction probability score demonstrated a probable (score of 5) relationship between rifampin and thrombocytopenia.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Although rifampin toxicities, such as hepatotoxicity and hematologic toxicity, are well known in the management of TB, there is a paucity of data describing toxicities in the setting of hardware infections. 3-7…”
“…Although rifampin has been implicated as a cause of thrombocytopenia, this adverse effect has been described primarily in the setting of complex TB regimens. [3][4][5][6][7] While early reports described hematologic toxicities with ≥600 mg/ day, it should be noted that toxicities have also occurred with lower intermittent dosing regimens. [3][4][5][6][7] Therefore, the 300-to 450-mg twice-daily rifampin regimens recommended for PJIs may place patients at increased risk of developing hematologic toxicities.…”
Section: Discussionmentioning
confidence: 99%
“…[3][4][5][6][7] While early reports described hematologic toxicities with ≥600 mg/ day, it should be noted that toxicities have also occurred with lower intermittent dosing regimens. [3][4][5][6][7] Therefore, the 300-to 450-mg twice-daily rifampin regimens recommended for PJIs may place patients at increased risk of developing hematologic toxicities. 1,2 Utilization of the Naranjo adverse drug reaction probability score demonstrated a probable (score of 5) relationship between rifampin and thrombocytopenia.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 Although rifampin toxicities, such as hepatotoxicity and hematologic toxicity, are well known in the management of TB, there is a paucity of data describing toxicities in the setting of hardware infections. 3-7…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.